Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared With Non-cancer TissuesOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study compared the mucosa-associated bacterial community of gastric cancer tissue with each patient's own adjacent non-cancer tissue, using paired samples to control for host genetics and environment, and profiled composition, co-occurrence networks, and predicted functions by 16S rRNA (V4 to V5) sequencing.
Who was studied?
124 gastric mucosa samples (cancer plus paired adjacent non-cancer) from 62 gastric adenocarcinoma patients who underwent subtotal gastrectomy at the First Hospital of China Medical University (2012 to 2014), median age 60, excluding anyone recently treated with antibiotics, proton-pump inhibitors, probiotics, chemotherapy, or radiotherapy.
What were the most important findings?
Tumor tissue showed higher microbial richness and diversity than non-cancer tissue, with a denser co-occurrence network. Proteobacteria dominated both groups but were relatively lower in cancer, while Firmicutes, Bacteroidetes, Actinobacteria, and Fusobacteria rose. LEfSe flagged 49 differentially abundant taxa (LDA above 3): 33 enriched in cancer, largely oral bacteria such as Peptostreptococcus, Streptococcus, and Fusobacterium, and 16 enriched in non-cancer tissue, largely lactic-acid bacteria. Predicted purine-metabolism and denitrification functions were enriched in the cancer community.
What are the greatest implications of this study?
The results point to translocated oral bacteria, rather than Helicobacter pylori alone, as a feature of the gastric-cancer microenvironment and a possible contributor to or marker of carcinogenesis. As a cross-sectional tissue study, it establishes association rather than causation.